12 stories from 7 sources

Kenya’s Ebola cluster leads a day of provisional cancer advances

Day’s Recap

Supporting Articles

5:46 AMBBC

Woman, 65, becomes second patient to die of Ebola in Kenya

Summary

A 65-year-old woman has become Kenya’s second Ebola fatality. She was a close relative of the first victim, a man who had travelled from the Democratic Republic of Congo.

The second fatality confirms that the imported case generated at least one subsequent infection within

Why it matters

The case shows how quickly an imported infection can establish local transmission before authorities have fully mapped contacts.

Link to Story

12:41 AMBloomberg Markets

Kenya Records Second Ebola Death as Uganda Restricts Transit

Summary

Kenya has recorded a second Ebola death, involving a 65-year-old woman who was a close family member of the country’s first reported case.

The linked deaths indicate household transmission rather than an isolated imported case. Kenyan authorities now

Why it matters

A second death tied to the index case raises the risk that Ebola is spreading beyond the first known patient’s immediate contacts.

Link to Story

2 stories · 2 sources

10:30 AMCNBC

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

Summary

Amgen said its drug reduced the risk of death by 58% when combined with an AstraZeneca immunotherapy in patients with an aggressive form of lung cancer. The result comes from a company-reported trial and will require detailed data and regulatory review to assess its clinical significance.

The reported result could strengthen a combination-treatment approach for patients with limited options, but a

Why it matters

If confirmed, the combination could reshape treatment for a particularly deadly lung cancer and expand the role of immunotherapy-based regimens.

Link to Story

8:00 PMNature

ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2

Summary

The study examines whether clearing circulating tumor DNA during neoadjuvant treatment predicts outcomes for patients with resectable lung cancer in the NeoCOAST-2 trial. Patients whose ctDNA became undetectable had stronger treatment responses and better subsequent outcomes than those with persistent ctDNA.

ctDNA clearance could provide an early readout of whether preoperative therapy is working, before surgery

Why it matters

A blood-based measure of residual cancer could make perioperative lung cancer treatment more precisely adaptive.

Link to Story

Other Developments

A curated list of other prominent stories from this day.

3:12 PMBBC

Vanessa Trump says she is cancer-free six months after revealing diagnosis

Summary

Vanessa Trump said she is cancer-free six months after announcing that she had been diagnosed with breast cancer. She shares five children with Donald Trump Jr.

Her statement signals a positive treatment outcome but does not establish remission duration, recurrence risk,

Why it matters

The update may encourage screening and treatment awareness, but individual recovery claims cannot substitute for clinical evidence or personalized medical advice.

Link to Story

1:00 PMStat News

STAT+: The ESMO presentation everyone’s been waiting for

Summary

Day 2 of the European Society for Medical Oncology meeting in Madrid featured the closely watched presentation from Moderna and Merck, along with other oncology developments. The session was the central event of the meeting so far.

The Moderna-Merck presentation now sets the near-term benchmark for how investors and oncologists assess the

Why it matters

The presentation could influence the next wave of clinical, regulatory, and commercial decisions in cancer care.

Link to Story

9:15 AMScienceDaily

Could lowering high blood pressure be as simple as stimulating your ear?

Summary

A small device that stimulates nerves through the ear was safe and well tolerated in a trial of 63 people with hypertension who were already taking medication. It did not significantly beat placebo across the full group, but participants with more severe hypertension saw promising blood-pressure reductions.

The main finding is a potential signal in patients whose hypertension remains difficult to control,

Why it matters

A noninvasive add-on treatment could expand options for people whose blood pressure stays high despite standard drugs.

Link to Story

9:05 AMCNBC

Fact vs. fiction: Doctors share whether peptides are safe and effective

Summary

Doctors assess the safety and effectiveness of peptide products as interest grows among wellness influencers and government officials. Their guidance addresses what these products can and cannot prove as treatments.

The central issue is that 'peptides' covers very different compounds, from established medicines to poorly

Why it matters

Growing demand could push more people toward unapproved peptide products before regulators and researchers establish which uses are safe.

Link to Story

7:52 AMScienceDaily

Your blood could reveal inflammatory bowel disease 10 years before diagnosis

Summary

Researchers found antibody patterns in blood that preceded diagnoses of Crohn's disease and ulcerative colitis by as much as a decade. The patterns also appeared to distinguish people more likely to develop complicated disease.

The shift is toward identifying inflammatory bowel disease before symptoms lead to diagnosis, when monitoring

Why it matters

Earlier risk detection could reduce diagnostic delays and help target surveillance to people most likely to develop severe disease.

Link to Story

7:16 AMScienceDaily

Scientists discover a hidden switch that burns fat and blocks new fat cells

Summary

Scientists found that disabling a protein called Mitch caused human cells to burn more fat and limited the formation of new fat cells. Related mouse experiments linked the change to resistance to obesity and better muscular endurance, but the treatment potential remains untested in people.

The decisive gap is between a promising cellular mechanism and a safe human therapy. Blocking

Why it matters

The discovery points to a possible obesity treatment that changes fat biology rather than relying only on appetite suppression.

Link to Story

7:00 AMStat News

Opinion: Christina Applegate puts a face on one of the most consequential challenges in neurology

Summary

The piece argues that Christina Applegate's experience with multiple sclerosis underscores a central problem in neurology: patients need accurate diagnoses, not merely faster ones. Misidentifying MS can send patients toward inappropriate treatment while delaying care for the actual condition.

Diagnostic accuracy remains the decisive challenge because MS symptoms can overlap with those of other

Why it matters

An incorrect MS diagnosis can expose patients to unnecessary treatment while the real disease continues untreated.

Link to Story

1:20 AMAl Jazeera

Hospital in Yemen’s Taiz warns of collapse in days because of Houthi siege

Summary

A hospital in Taiz says shortages of fuel, medicines, and oxygen could force it to collapse within days. Dialysis patients are already receiving shorter treatment sessions because supplies are running out.

The siege is converting shortages into direct treatment cuts, with dialysis patients among the first

Why it matters

A hospital shutdown would turn an existing humanitarian crisis into an immediate threat to patients who require continuous, resource-intensive care.

Link to Story

Make it yours

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!